Study guide

8.6 APRV in Pediatric Respiratory Failure

NBRC RRT-NPS Neonatal/Pediatric Specialist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neonatal and Pediatric Patient Assessment

1.1 Maternal, Obstetric & Perinatal History 1.2 Fetal Surveillance & Antepartum Diagnostics 1.3 Gestational Age & Baseline Neonatal Examination 1.4 Apgar, Respiratory Distress & Thoracic Assessment 1.5 Pediatric Assessment Triangle & Vital Signs 1.6 Neurologic Assessment, Respiratory Failure & Triage

2 Chapter 2: Diagnostic Evaluation & Gas Exchange Monitoring

2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring 2.2 Capnography, Waveforms & Dead-Space Evaluation 2.3 Arterial & Capillary Blood-Gas Sampling 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation 2.5 Chest Imaging & Airway Radiography 2.6 Pulmonary Function, Bronchoscopy & Specimen Diagnostics

3 Chapter 3: Airway Management & Secretion Clearance

3.1 Pediatric Airway Anatomy & ETT Sizing 3.2 Cuffed Airways, Intubation & Difficult-Airway Management 3.3 Tracheostomy Devices & Routine Care 3.4 Tracheostomy Emergencies, Speaking & Decannulation 3.5 Airway Suctioning Technique & Safety 3.6 Airway Clearance, Home Care & Discharge Planning

4 Chapter 4: Pharmacology & Medical Gas Therapy

4.1 Aerosol Physics & Delivery Devices 4.2 Respiratory & Systemic Pharmacology 4.3 Oxygen Interfaces & Delivery Systems 4.4 Oxygen Blenders, Targets & Toxicity 4.5 HFNC Physiology, Sizing & Flow 4.6 HFNC Indications, Monitoring & Escalation

5 Chapter 5: Shared Neonatal & Pediatric Pulmonary Disorders

5.1 Neonatal RDS Pathophysiology & Management 5.2 TTN, Pneumonia & the Neonatal Differential 5.3 Meconium Aspiration & PPHN 5.4 BPD, Apnea & Chronic Neonatal Lung Disease 5.5 Bronchiolitis, Croup & Epiglottitis 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration

6 Chapter 6: Resuscitation, Emergency Protocols & Patient Safety

6.1 NRP Cord Management, Initial Steps & Ventilation 6.2 NRP Corrective Steps, Compressions & Medications 6.3 PALS Assessment, CPR & Cardiac Arrest 6.4 PALS Dysrhythmia & Shock Management 6.5 Neonatal & Pediatric Transport 6.6 Patient Safety, Teamwork & Family-Centered Care

7 Chapter 7: Noninvasive & Conventional Mechanical Ventilation

7.1 Bubble CPAP & Neonatal NIV 7.2 Pediatric NIV, Interfaces & Failure Recognition 7.3 Conventional Ventilation Physics & Modes 7.4 Initial Settings & ABG-Guided Titration 7.5 Ventilator Scalars & Loops 7.6 Ventilator Dyssynchrony & Troubleshooting 7.7 Weaning Readiness & Spontaneous Breathing Trials 7.8 Extubation & Post-Extubation Airway Risk

8 Chapter 8: High-Frequency Ventilation & Advanced Modes

8.1 HFOV Mechanics & Gas Transport 8.2 HFOV Controls & Clinical Management 8.3 HFJV Circuit & Controls 8.4 HFJV Servo Pressure & Clinical Indications 8.5 NAVA, Edi & Proportional Support 8.6 APRV in Pediatric Respiratory Failure

9 Chapter 9: Specialty Inhaled Gases & Exogenous Surfactant Therapy

9.1 Inhaled Nitric Oxide: Mechanism, Indications & Dose 9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning 9.3 Heliox Physics & Delivery 9.4 Volatile Anesthetic & Subambient Gas Therapy 9.5 Surfactant Biology, Products & Dosing 9.6 Surfactant Administration & Response

10 Chapter 10: Pediatric ARDS & Parenchymal Critical Illness

10.1 PALICC-2 Diagnosis & Severity 10.2 PALICC-2 NIV & Possible PARDS 10.3 PARDS Lung-Protective Ventilation 10.4 PARDS Refractory Hypoxemia & Adjuncts 10.5 PIE & Pneumothorax Recognition 10.6 Thoracic Decompression & Chest Drains

11 Chapter 11: Congenital Heart Disease & Hemodynamic Management

11.1 Left-to-Right Shunts & Qp/Qs Physiology 11.2 Acyanotic Lesions & Respiratory Management 11.3 Cyanotic Lesions & the Five Ts 11.4 Ductal Dependence, PGE1 & the Hyperoxia Test 11.5 Single-Ventricle Physiology & Staged Palliation 11.6 Gas Balancing, Hemodynamics & NIRS

12 Chapter 12: Advanced Critical Care: ECMO, Neurotrauma & Palliative Care

12.1 ECMO Candidacy & Modality 12.2 ECMO Circuit, Lung Rest & Anticoagulation 12.3 Neurotrauma, ICP & Ventilation 12.4 Neonatal Therapeutic Hypothermia & Respiratory Care 12.5 Death by Neurologic Criteria: Examination & Apnea Testing 12.6 DNC Timing, Ancillary Testing, Palliation & Donation

8.6 APRV in Pediatric Respiratory Failure

Key Takeaways Explain This Topic AI

APRV alternates a prolonged high-pressure phase with brief releases and can permit spontaneous breathing. Pediatric evidence and implementation vary, so use a defined institutional protocol and monitor hemodynamics, effort, gas exchange, and lung volume.

T_low may be adjusted from expiratory-flow termination in some protocols, but 75% of peak expiratory flow, P_low of zero, and fixed pressure/time ranges are not universal pediatric requirements.

Delivered NAVA pressure equals PEEP plus (NAVA level x [Edi peak minus Edi min]), so a PEEP of 6, a NAVA level of 1.5 cmH2O per microvolt, and an Edi swing of 10.8 microvolts give about 22 cmH2O.

NAVA cannot function after neuromuscular blockade because the Edi signal falls to zero and the ventilator reverts to apnea back-up ventilation.

Last updated: September 2026

  • 8.6 APRV in Pediatric Respiratory Failure
  • Airway Pressure Release Ventilation (APRV) in Pediatrics

Airway Pressure Release Ventilation (APRV) is an advanced open-lung mode designed for patients with severe, heterogeneous acute lung injury and Pediatric Acute Respiratory Distress Syndrome (PARDS). Airway Pressure (cmH2O)

  • ^
  • | +--------------------------+ +--------------------------+
  • P_high |---| | | |
  • | | | | |
  • | | (Spontaneous Breaths | | (Spontaneous Breaths |
  • | | at High CPAP) | | at High CPAP) |
  • | | | | |
  • P_low |--------------------------+--+-------+--------------------------+--+-----> Time
  • |<------- T_high --------->|<-T_low->||<------- T_high --------->|<-T_low->|
  • Core Principles of APRV

Continuous CPAP with Intermittent Releases: APRV applies a continuous high airway pressure ( P high P_{\text{high}} P high ​ ) for the vast majority of the respiratory cycle ( T high T_{\text{high}} T high ​ ) to promote alveolar recruitment. It then intermittently releases pressure to a lower baseline ( P low P_{\text{low}} P low ​ ) for a brief interval ( T low T_{\text{low}} T low ​ ) to facilitate carbon dioxide elimination.

Unrestricted Spontaneous Breathing: The patient is free to take unassisted, spontaneous breaths at any point during the cycle, primarily at the P high P_{\text{high}} P high ​ plateau. Spontaneous breathing improves dependent lung ventilation, preserves diaphragmatic tone, enhances cardiac venous return, and reduces heavy sedation requirements.

  • Core APRV Settings & Titration +-----------------------------------------------------------------------------+
  • | APRV PARAMETER TARGETS |
  • +-------------------+---------------------------------------------------------+
  • | Parameter | Pediatric Clinical Setting & Titration Target |
  • +-------------------+---------------------------------------------------------+
  • | P_high | 20 to 28 cmH2O (matched to conventional plateau press) |
  • +-------------------+---------------------------------------------------------+
  • | T_high | 3.0 to 6.0 seconds (accounts for 80% to 90% of cycle) |
  • +-------------------+---------------------------------------------------------+
  • | P_low | 0 cmH2O (maximizes gas egress gradient to dump CO2) |
  • +-------------------+---------------------------------------------------------+
  • | T_low | 0.2 to 0.6 seconds (CRITICAL: set by expiratory flow) |
  • +-------------------+---------------------------------------------------------+
  • The Expiratory Flow Waveform Rule: Setting T low T_{\text{low}} T low ​

The release time ( T low T_{\text{low}} T low ​ ) is the most critical parameter in APRV. Setting T low T_{\text{low}} T low ​ too long causes complete alveolar derecruitment, whereas setting it too short causes severe carbon dioxide retention.

The 75% Peak Expiratory Flow Rate (PEFR) Rule:

The therapist must observe the expiratory flow-time scalar.

When the ventilator releases from P high P_{\text{high}} P high ​ to P low P_{\text{low}} P low ​ , gas accelerates rapidly to a negative peak (Peak Expiratory Flow Rate, PEFR).

Some APRV protocols adjust T low T_{\text{low}} T low ​ so expiration ends while substantial expiratory flow remains—often around 50%-75% of peak—but pediatric practice and ventilator algorithms differ. Use the protocol, flow curve, lung volume, CO2, and hemodynamic response.

Terminating the release while flow is still escaping traps gas inside the alveoli, creating intentional intrinsic PEEP (auto-PEEP) that keeps fragile alveoli stented open, preventing cyclic atelectotrauma. Expiratory Flow (L/min)

  • ^
  • 0 |------------------------------+ +------------------------------
  • | | |
  • | | |
  • | PEFR | | PEFR
  • | | | | |
  • | v | | v
  • | +----+ | | +----+
  • | | | | | | |
  • | | | | | | |
  • | | \ | | | \
  • | | \ <--- Terminate at 75% of PEFR | \ <--- Terminate at 75%
  • v +------\---------+ v +------\---------+
  • | |
  • |<-- T_low -->| |<-- T_low -->|
  • Clinical Comparison: Conventional PCV vs. NAVA vs. APRV

Feature Conventional Pressure Control (PCV) Neurally Adjusted Ventilatory Assist (NAVA) Airway Pressure Release Ventilation (APRV)

Triggering Mechanism Pneumatic (Flow or Pressure) Neural (Electrical Activity of Diaphragm, E d i Edi E d i ) Time-triggered baseline CPAP with spontaneous breaths

Pressure Modulation Fixed clinician-set inspiratory pressure Variable, proportional to E d i Edi E d i effort ( P ∝ E d i P \propto Edi P ∝ E d i ) Bi-level CPAP ( P high P_{\text{high}} P high ​ and P low P_{\text{low}} P low ​ )

Cycling Mechanism Time-cycled Neural cycling ( 70 % 70\% 70% of peak E d i Edi E d i ) Time-cycled ( T high T_{\text{high}} T high ​ and T low T_{\text{low}} T low ​ )

Vulnerability to Air Leaks Leak can disrupt triggering/cycling Neural trigger is often less leak-sensitive, not immune Continuous flow may compensate for some leak

Spontaneous Breathing Restricted to trigger window Continuous, entirely unconstrained Unrestricted throughout entire cycle

Diaphragmatic Disuse Atrophy High risk with deep sedation/paralysis Low risk (diaphragm remains actively recruited) Low risk (active spontaneous contraction encouraged)

Primary Clinical Indication Routine neonatal/pediatric ventilation Neonatal weaning, NIV, severe dyssynchrony Severe Pediatric ARDS with refractory hypoxemia

  • Worked Clinical Calculations
  • Calculation 1: Determining Delivered Pressure on NAVA

A 2-year-old child recovering from viral pneumonia is supported on invasive NAVA. Current settings:

  • PEEP: 6 cmH 2 O 6\text{ cmH}_2\text{O} 6 cmH 2 ​ O
  • NAVA Level: 1.5 cmH 2 O / μ V 1.5\text{ cmH}_2\text{O} / \mu\text{V} 1.5 cmH 2 ​ O / μ V
  • P max P_{\text{max}} P max ​ : 30 cmH 2 O 30\text{ cmH}_2\text{O} 30 cmH 2 ​ O

During a calm, resting breath, the monitor displays:

E d i peak Edi_{\text{peak}} E d i peak ​ : 12 μ V 12\ \mu\text{V} 12 μ V

E d i min Edi_{\text{min}} E d i min ​ : 1.2 μ V 1.2\ \mu\text{V} 1.2 μ V Delivered Airway Pressure = PEEP + ( NAVA Level × [ E d i peak − E d i min ] ) \text{Delivered Airway Pressure} = \text{PEEP} + (\text{NAVA Level} \times [Edi_{\text{peak}} - Edi_{\text{min}}]) Delivered Airway Pressure = PEEP + ( NAVA Level × [ E d i peak ​ − E d i min ​ ]) Delivered Airway Pressure = 6 + ( 1.5 × [ 12 − 1.2 ] ) = 6 + ( 1.5 × 10.8 ) = 6 + 16.2 = 22.2 cmH 2 O \text{Delivered Airway Pressure} = 6 + (1.5 \times [12 - 1.2]) = 6 + (1.5 \times 10.8) = 6 + 16.2 = 22.2\text{ cmH}_2\text{O} Delivered Airway Pressure = 6 + ( 1.5 × [ 12 − 1.2 ]) = 6 + ( 1.5 × 10.8 ) = 6 + 16.2 = 22.2 cmH 2 ​ O

If the child becomes agitated and pulls an E d i peak Edi_{\text{peak}} E d i peak ​ of 22 μ V 22\ \mu\text{V} 22 μ V with an E d i min Edi_{\text{min}} E d i min ​ of 2.0 μ V 2.0\ \mu\text{V} 2.0 μ V : Delivered Airway Pressure = 6 + ( 1.5 × [ 22 − 2.0 ] ) = 6 + ( 1.5 × 20 ) = 6 + 30 = 36 cmH 2 O \text{Delivered Airway Pressure} = 6 + (1.5 \times [22 - 2.0]) = 6 + (1.5 \times 20) = 6 + 30 = 36\text{ cmH}_2\text{O} Delivered Airway Pressure = 6 + ( 1.5 × [ 22 − 2.0 ]) = 6 + ( 1.5 × 20 ) = 6 + 30 = 36 cmH 2 ​ O

Because 36 cmH 2 O 36\text{ cmH}_2\text{O} 36 cmH 2 ​ O exceeds P max P_{\text{max}} P max ​ ( 30 cmH 2 O 30\text{ cmH}_2\text{O} 30 cmH 2 ​ O ), the ventilator clamps delivered pressure at P max − 5 = 25 cmH 2 O P_{\text{max}} - 5 = 25\text{ cmH}_2\text{O} P max ​ − 5 = 25 cmH 2 ​ O or the set P max P_{\text{max}} P max ​ limit to safeguard against barotrauma.

Calculation 2: Setting T low T_{\text{low}} T low ​ on APRV

A pediatric patient with severe ARDS exhibits a Peak Expiratory Flow Rate (PEFR) of − 40 L/min -40\text{ L/min} − 40 L/min on the expiratory flow scalar when releasing from P high P_{\text{high}} P high ​ .

Target termination flow: 75 % 75\% 75% of PEFR. Termination Flow = − 40 L/min × 0.75 = − 30 L/min \text{Termination Flow} = -40\text{ L/min} \times 0.75 = -30\text{ L/min} Termination Flow = − 40 L/min × 0.75 = − 30 L/min

The therapist adjusts T low T_{\text{low}} T low ​ on the ventilator until the valve closes and pressure returns to P high P_{\text{high}} P high ​ exactly when expiratory flow decelerates to − 30 L/min -30\text{ L/min} − 30 L/min . This prevents lung derecruitment.

  • NPS Exam Traps
  • Exam Trap 1: Sedation, Paralysis, and NAVA

On the NPS exam, if a patient on NAVA is administered a neuromuscular blocking agent (e.g., vecuronium, rocuronium) or heavy narcotic boluses that abolish central respiratory drive, candidates must recognize that the Edi signal will drop to zero . NAVA cannot function without active diaphragmatic electromyographic signals. When E d i Edi E d i ceases, the ventilator automatically drops into apnea back-up ventilation . You cannot use NAVA in a paralyzed patient.

Exam Trap 2: Troubleshooting Edi Catheter Malposition

If the ventilator monitor indicates an invalid E d i Edi E d i signal and the positioning window shows the highest amplitude signals in the topmost channel with large P-waves, the catheter has slipped upward into the esophagus. Do not increase the NAVA level or replace the catheter; simply advance the catheter deeper until the middle channels highlight blue.

Exam Trap 3: Titrating T_low in Pediatric APRV

When an arterial blood gas shows hypercapnia in a child on APRV, candidates often instinctively lengthen T low T_{\text{low}} T low ​ to allow "more time for exhalation." In APRV, prolonging T low T_{\text{low}} T low ​ beyond the 75 % 75\% 75% PEFR cutoff causes catastrophic alveolar collapse (derecruitment) , worsening both hypoxemia and lung compliance. To blow off more C O 2 CO_2 C O 2 ​ safely, the clinician should slightly reduce T high T_{\text{high}} T high ​ (increasing release frequency) or optimize spontaneous breathing.